Intravitreal enzyme replacement therapy to prevent retinal disease progression in children with neuronal ceroid lipofuscinosis type 2 (CLN2): Unilateral injection results

被引:0
|
作者
Rogers, David L. [1 ]
de los Reyes, Emily C. [1 ]
Mendel, Thomas A. [2 ]
Caprul, Brian J. [1 ]
Podlasiak, Sarah [1 ]
Jordan, Catherine O. [1 ]
机构
[1] Nationwide Childrens Hosp, Columbus, OH USA
[2] Ohio State Univ, Wexner Med Ctr, Columbus, OH USA
关键词
D O I
10.1016/j.ymgme.2023.108019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
280
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Expert recommendations for the laboratory diagnosis of neuronal ceroid lipofuscinosis type 2 (CLN2 disease): Diagnostic algorithm and best practice guidelines for a timely diagnosis
    Giugliani, Roberto
    Fietz, Michael
    Al-Sayed, Moeenaldeen
    Burke, Derek
    Cohen-Pfeffer, Jessica
    Cooper, Jonathan D.
    Noher de Halac, Ines
    Dvorakova, Lenka
    Izzo, Emanuela
    Jahnova, Helena
    Lukacs, Zoltan
    Mole, Sara
    Pearce, David
    Schulz, Angela
    Specchio, Nicola
    Xin, Winnie
    Miller, Nicole
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S61 - S61
  • [42] DNA and enzyme diagnostics for tripeptidyl peptidase I (CLN2) involved in classical late infantile neuronal ceroid lipofuscinosis.
    Franken, PF
    Keulemans, JLM
    Breuning, MH
    Van Diggelen, OP
    Taschner, PEM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A235 - A235
  • [43] Mutation update: Review of TPP1 gene variants associated with neuronal ceroid lipofuscinosis CLN2 disease
    Gardner, Emily
    Bailey, Mitch
    Schulz, Angela
    Aristorena, Mikel
    Miller, Nicole
    Mole, Sara E.
    HUMAN MUTATION, 2019, 40 (11) : 1924 - 1938
  • [44] Real-world Experience in the Diagnosis of Neuronal Ceroid Lipofuscinosis Type 2 (CLN2): Report from an International Collaboration of Experts
    de los Reyes, E.
    Cohen-Pfeffer, J. L.
    Crystal, R.
    Yoshikatsu, E.
    Fietz, M.
    Heron, B.
    Izzo, E.
    Kohlschutter, A.
    Lourenco, C. M.
    Mole, S.
    Noher de Halac, I
    Pearce, D. A.
    Schulz, A.
    Simonati, A.
    Poyato, del Socorro Perez M.
    Miller, N.
    ANNALS OF NEUROLOGY, 2015, 78 : S196 - S196
  • [45] NEURONAL CEROID LIPOFUSCINOSIS-2 (CLN2) DISEASE, A TYPE OF BATTEN DISEASE CAUSED BY TPP1 ENZYME DEFICIENCY: CURRENT KNOWLEDGE OF THE NATURAL HISTORY FROM INTERNATIONAL EXPERTS
    Schulz, Angela
    Cohen-Pfeffer, Jessica
    Crystal, Ronald
    de los Reyes, Emily
    Eto, Yoshikatsu
    Guelbert, Norberto
    Heron, Benedicte
    Mikhailova, Svetlana
    Miller, Nicole
    Mink, Jonathan W.
    Socorro Perez-Poyato, Maria
    Simonati, Alessandro
    Sims, Katherine
    Williams, Ruth E.
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (03) : 283 - 284
  • [46] Intravitreal Cerliponase alfa for the treatment of CLN2 type Batten Disease related retinal dystrophy: A first in man report of ocular enzyme replacement
    Wawrzynski, James
    Gissen, Paul
    Bowman, Richard
    Bower, Rebecca
    Gan, Chin
    Harding, Louise
    Mortensen, Amanda
    Thompson, Dorothy
    Henderson, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [47] Next-generation sequencing in childhood-onset epilepsies: Diagnostic yield and impact on neuronal ceroid lipofuscinosis type 2 (CLN2) disease diagnosis
    Gall, Kimberly
    Izzo, Emanuela
    Seppala, Eija H.
    Alakurtti, Kirsi
    Koskinen, Lotta
    Saarinen, Inka
    Singh, Akashdeep
    Myllykangas, Samuel
    Koskenvuo, Juha
    Alastalo, Tero-Pekka
    PLOS ONE, 2021, 16 (09):
  • [48] Neuronal Ceroid Lipofuscinosis-2 (CLN2) Disorder, a Type of Batten Disease Caused by TPP1 Enzyme Deficiency: current knowledge of the natural history from international experts
    de Los Reyes, E.
    Cohen-Pfeffer, J. L.
    Crystal, R.
    Eto, Y.
    Guelbert, N.
    Heron, B.
    Mikhailova, S.
    Miller, N.
    Mink, J.
    Perez-Poyato, M. S.
    Simonati, A.
    Sims, K.
    Williams, R.
    Schulz, A.
    ANNALS OF NEUROLOGY, 2015, 78 : S195 - S196
  • [49] Neuronal ceroid lipofuscinosis type CLN2: A new rationale for the construction of phenotypic subgroups based on a survey of 25 cases in South America
    Kohan, Romina
    Noelia Carabelos, Maria
    Xin, Winnie
    Sims, Katherine
    Guelbert, Norberto
    Adriana Cismondi, Ines
    Pons, Patricia
    Irene Alonso, Graciela
    Troncoso, Monica
    Witting, Scarlet
    Pearce, David A.
    Dodelson de Kremer, Raquel
    Maria Oller-Ramirez, Ana
    Noher de Halac, Ines
    GENE, 2013, 516 (01) : 114 - 121
  • [50] Untargeted Metabolite Profiling of Cerebrospinal Fluid Uncovers Biomarkers for Severity of Late Infantile Neuronal Ceroid Lipofuscinosis (CLN2, Batten Disease)
    Miriam Sindelar
    Jonathan P. Dyke
    Ruba S. Deeb
    Dolan Sondhi
    Stephen M. Kaminsky
    Barry E. Kosofsky
    Douglas J. Ballon
    Ronald G. Crystal
    Steven S. Gross
    Scientific Reports, 8